Purification engineering technology research center of Sichuan Province Natural Medicine
四川省天然藥物分離純化工程技術(shù)研究中心
文獻(xiàn)
Qiaoxia Wang, et al."Exploring the mechanism and effective compounds of Changan Granule on diarrhea-predominant irritable bowel syndrome via regulating 5-hydroxytryptamine signaling pathway in brain-gut axis."Phytomedicine 136.(2025):156350-156350.
本文來自: 發(fā)布時(shí)間:2025-12-19
發(fā)表期刊:Phytomedicine
發(fā)表時(shí)間:2025
Abstract:
Background
Changan Granule (CAG) is a drug product developed from a traditional Chinese medicine (TCM) empirical prescription for diarrhea-predominant irritable bowel syndrome (IBS-D). The action mechanism and effective compounds of CAG in the treatment of IBS-D are not well understood.
Purpose
This study aimed to investigate the effectiveness, action mechanism and effective compounds of CAG for treating IBS-D.
Methods
Network pharmacology was used to screen the related pathways and active compounds of CAG in the treatment of IBS-D. Neonatal mother-infant separation, acetic acid enema and colorectal dilation were employed to construct IBS-D model for in vivo study. The effectiveness of CAG was evaluated in accordance with the results of body weight measurement, fecal water content determination, abdominal withdraw reflex test, open field test, sucrose preference test, forced swimming test and hematoxylin-eosin (HE) staining. The protein and mRNA levels of key molecules regulated by CAG were assessed through enzyme-linked immunosorbent assay (ELISA), western blotting, and reverse transcription quantitative polymerase chain reaction (RT-qPCR). The active compounds from CAG screened by network pharmacology were investigated with Caco-2 and RIN-14B cell models in vitro.
Results
Network pharmacological analysis showed that CAG regulated 5-hydroxytryptamine (5-HT) signaling pathway and tetrahydropalmatine, formononetin and corydaline might be the potential effective compounds. The validation experiments showed that CAG restored the decreased body weight, and alleviated intestinal sensitivity, low-grade inflammation, diarrhea, frequent defecation, anxiety and depression of IBS-D rats through regulating the expression levels of 5-HT, tryptophan hydroxylase (TPH)1/2, serotonin transporter (SERT), 5-hydroxytryptamine-3 and -4 receptors (5-HT3R and 5-HT4R) in brain-gut axis (BGA). Tetrahydropalmatine and formononetin were confirmed to be the potential effective compounds of CAG in regulating 5-HT signaling pathway.
Conclusion
CAG exhibits therapeutic effect on IBS-D rats through regulating 5-HT signaling pathway in BGA. Tetrahydropalmatine and formononetin are major potential effective compounds. Our findings provide scientific basis for the clinical use and drug development of CAG for IBS-D.
https://doi.org/10.1016/j.phymed.2024.156350

聯(lián)系我們
4000-369-963 028-85370565
18080489829@163.com
四川省 成都市 武侯區(qū) 武科西二路8號(hào)
關(guān)于普思
產(chǎn)品
技術(shù)服務(wù)

普思生物為您提供中藥化學(xué)對(duì)照品、高純化學(xué)試劑、天然產(chǎn)物化合物庫(kù)等優(yōu)質(zhì)產(chǎn)品,
僅用于科學(xué)研究、工業(yè)應(yīng)用等非醫(yī)療用途范疇,不可用于人的臨床治療或試驗(yàn),非藥用,非食用。
友情鏈接:全球化學(xué)品供應(yīng)商搜索 蓋德化工網(wǎng) 成都普思生物科技股份有限公司版權(quán)所有 蜀ICP備08100078號(hào)
咨詢
熱線
4000-369-963
7*24小時(shí)客服服務(wù)熱線
關(guān)注
微信
關(guān)注官方微信